We are live on
!
Find out more
HCM
Highline Capital Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
21.72%
This Fund
S&P 500
This Quarter
Est. Return
-17.63%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
-$670M
(-31%)
Cap. Flow
-$327M
Cap. Flow
% of AUM
-21.94%
Top 10 Holdings %
Top 10 Hldgs %
63.63%
Holding
47
New
15
Increased
9
Reduced
8
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BERY
Berry Global Group, Inc.
BERY
|
+$108M |
| 2 |
GRA
W.R. Grace & Co.
GRA
|
+$108M |
| 3 |
Elevance Health
ELV
|
+$93M |
| 4 |
I
INTELSAT S. A.
I
|
+$40.8M |
| 5 |
MTOR
MERITOR, Inc.
MTOR
|
+$39.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$135M |
| 2 |
Bunge Global
BG
|
+$110M |
| 3 |
Spotify
SPOT
|
+$104M |
| 4 |
Intercontinental Exchange
ICE
|
+$85.7M |
| 5 |
Amazon
AMZN
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 30.48% |
| 2 | Healthcare | 29.52% |
| 3 | Materials | 14.53% |
| 4 | Real Estate | 9.43% |
| 5 | Technology | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$34.7B
| $115M | 7.68% |
986,131
-469,169
| -32% | -$56.8M |
|
|
BERY
2
DELISTED
Berry Global Group, Inc.
BERY
| $111M | 7.42% |
+2,535,926
| New | +$108M |
|
|
GRA
3
DELISTED
W.R. Grace & Co.
GRA
| $108M | 7.27% |
+1,670,400
| New | +$108M |
|
4
Royal Caribbean
RCL
$78.7B
| $106M | 7.07% |
1,078,950
+271,950
| +34% | +$29.8M |
|
5
Equinix
EQIX
$107B
| $101M | 6.75% |
285,615
-107,935
| -27% | -$42.1M |
|
|
6
Elevance Health
ELV
$81.9B
| $88.8M | 5.95% |
+338,064
| New | +$93M |
|
7
BioMarin Pharmaceuticals
BMRN
$11.5B
| $86.3M | 5.78% |
1,013,119
-273,831
| -21% | -$26M |
|
8
Caesars Entertainment
CZR
$6.1B
| $82.8M | 5.55% |
2,287,099
-536,462
| -19% | -$21.3M |
|
9
ServiceNow
NOW
$102B
| $78.1M | 5.24% |
2,194,425
+44,425
| +2% | +$1.58M |
|
|
CZR
10
DELISTED
Caesars Entertainment Corporation
CZR
| $73.6M | 4.93% |
10,837,322
-1,835,612
| -14% | -$15.5M |
|
11
Commercial Metals
CMC
$7.63B
| $52.1M | 3.49% |
3,252,508
+671,091
| +26% | +$12.5M |
|
12
Boyd Gaming
BYD
$6.47B
| $45.1M | 3.02% |
2,170,939
-389,061
| -15% | -$10.2M |
|
13
VICI Properties
VICI
$29.4B
| $40M | 2.68% |
2,131,260
-123,740
| -5% | -$2.6M |
|
|
MTOR
14
DELISTED
MERITOR, Inc.
MTOR
| $39.4M | 2.64% |
+2,330,180
| New | +$39.7M |
|
15
Pegasystems
PEGA
$4.41B
| $34.2M | 2.29% |
1,428,676
+520,676
| +57% | +$13.7M |
|
|
I
16
DELISTED
INTELSAT S. A.
I
| $32.3M | 2.16% |
+1,509,683
| New | +$40.8M |
|
17
Rio Tinto
RIO
$148B
| $32.1M | 2.15% |
+661,857
| New | +$32.3M |
|
18
Vale
VALE
$62.9B
| $26.6M | 1.78% |
+2,017,848
| New | +$28.8M |
|
|
FPAC.U
19
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $25.1M | 1.69% |
2,492,099
| – | – |
|
20
Regenxbio
RGNX
$623M
| $23.4M | 1.57% |
558,612
+216,612
| +63% | +$12.7M |
|
21
Moderna
MRNA
$21.5B
| $23.2M | 1.55% |
+1,517,942
| New | +$24.9M |
|
22
ArcelorMittal
MT
$50.4B
| $23M | 1.54% |
+1,113,695
| New | +$27.6M |
|
23
Ultragenyx Pharmaceutical
RARE
$2.65B
| $19.9M | 1.34% |
458,513
+30,393
| +7% | +$1.66M |
|
24
UroGen Pharma
URGN
$2B
| $19.9M | 1.33% |
461,678
+129,778
| +39% | +$5.83M |
|
25
Atara Biotherapeutics
ATRA
$71.2M
| $18M | 1.21% |
20,735
+11,639
| +128% | +$10.8M |
|
Similar funds
NHSP
DTIM
BI
MCAI
PCM
FC
AEPIP
SAM
Highline Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Highline Capital Management held 47 positions worth $1.49B, down 31% from $2.16B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Highline Capital Management withdrew a net $327M in Q4 2018, closing 13 positions and reducing 8 holdings. Its most notable exit was Tiffany & Co., an estimated $135M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Materials.
Against the trend, Highline Capital Management opened a new position in Berry Global Group, Inc. worth $111M.
- Highline Capital Management's largest Q4 2018 buy was Berry Global Group, Inc.: 2,535,926 shares worth $111M.
- Highline Capital Management added most to Royal Caribbean in Q4 2018, an estimated $29.8M increase.
- Highline Capital Management's biggest Q4 2018 reduction was Conduent, cutting an estimated $66.3M.
- Highline Capital Management fully exited Tiffany & Co. in Q4 2018, selling an estimated $135M.
- Highline Capital Management's ten largest holdings make up 64% of its $1.49B portfolio in Q4 2018.
- Highline Capital Management opened 15 new positions and closed 13 in Q4 2018.
- Highline Capital Management's portfolio value fell 31% quarter-over-quarter to $1.49B.
Based on Highline Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.